glp-1 obesity drug news updates Upcoming wave of hormone-based therapies set to change field of diabetes, care Risks of Ozempic, other GLP-1
Description
The global appetite for GLP-1 medications like Ozempic, Wegovy and Mounjaro have created something far more dangerous than a cultural trend
Mounjaro is dual-acting, while Ozempic affects one gut hormone.
Could it be because Indian physicians are conservative when it comes to prescribing newer drugs
Free from gluten, dairy, soy, sugar, and artificial additives, this product caters to those seeking a mindful approach to wellness
GLP-1 Receptor Agonist Market size is growing with a CAGR of 12.5% in the prediction period and it crosses USD 72.33 Bn by 2033 from USD 31.71 Bn in 2026.
